Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel
NCT01095640 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1159
Last updated 2010-03-30
Summary
Marketed by Galderma Laboratories, L.P., Differin® (adapalene 0.3% topical gel) is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC has developed a generic formulation of adapalene 0.3% topical gel and the current study is designed to evaluate the safety and efficacy of this formulation.
Conditions
- Acne Vulgaris
Interventions
- DRUG
-
adapalene 0.3% topical gel
once a day, 84 days
Sponsors & Collaborators
-
Actavis Mid-Atlantic LLC
lead INDUSTRY
Principal Investigators
-
Vishal B., MD · Yenepoya Medical College
-
Bela J. Shah, MD · GMC and SSG Hospital
-
Mhaske, MD · B. J. Medical College and Hospital
-
Manoj K. Parekh, MD · Bhagwan Mahaveer Jain Hospital
-
V. R. Sardesai, MD · Bharati Vidyapeeth University Medical College & Hospital
-
Kailash Bhatia, MD · Bhatia Skin Laser & Cosmetic Centre
-
Leelavathy B., MD · Bowring & Lady Curzon Hospital
-
Rajkumar V., MD · Dhanawantari Polyclinic
-
Mukta Sachdev, MD · Dr. Mukta Skin Clinic
-
Anilkumar Malik, MD · G.M Modi Hospital
-
Yogesh Marfatia, MD · GMC and SSG Hospital
-
Mahendra M. Kura, MD · Grant Medical College & Sir JJ Group of Hospitals
-
Jayadev Betkerur, MD · J.S.S. Medical College Hospital
-
Manjunath S. M., MD · Justice K.S. Hegde Charitable Hospital
-
Ramesh M., MD · Kempegowda Institute of Medical Sciences
-
Hemanji R. Jerajani, MD · L.T.M. Medical College & General Hospital
-
Vijaykumar Garg, MD · Maulana Azad Medical College Hospital
-
Rajitha K., MD · Medwin Hospital
-
Putta Srinivas, MD · Osmania General Hospital
-
Alur S. Kumar, MD · Owaisi Hospital & Research Centre
-
Jayesh Kothari, MD · Skin Clinic
-
P. V. S. Prasad, MD · Rajah Muthiah Medical College Hospital
-
D. N. Balraj, PI · Rajbal Skin Clinic
-
Sailaja K. Surapaneni, MD · SRI Medical Aesthetic and Cosmetic Surgery
-
Ravi M. Rathod, MD · Skin Care Centre
-
Ranjan C. Raval, MD · Smt. NHL Medical College and V.S. Hospital
-
V. K. Somani, MD · Somani Skin and Cosmetology Institute
-
Rachita Dhurat, MD · T. N. Medical College and BYL Nair hospital
-
P. V. Patalay, MD · Vani Skin Clinic
-
Nataraja, MD · Victoria Hospital
-
Karigi Siddalingappa, MD · Vijayanagara Institute Of Medical Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2009-12-31
- Completion
- 2009-12-31
Countries
- India
Study Locations
More Related Trials
-
Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%
NCT00660985 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%
NCT00599521 ·Status: COMPLETED ·Phase: PHASE3
-
Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne
NCT00469755 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%
NCT00598832 ·Status: COMPLETED ·Phase: PHASE3
-
Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage
NCT00647556 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris
NCT00160394 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris
NCT00441415 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris
NCT03615768 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
NCT00421993 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris
NCT02651220 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
NCT00422240 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
NCT02537483 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris
NCT00671749 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris
NCT01014689 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
NCT01209949 ·Status: COMPLETED ·Phase: PHASE4
-
Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars
NCT02735421 ·Status: COMPLETED ·Phase: PHASE4
-
Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
NCT01046396 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris
NCT00696449 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-V
NCT07015931 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars
NCT01213199 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris
NCT02709902 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris
NCT01501799 ·Status: COMPLETED ·Phase: NA
-
Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
NCT01046565 ·Status: COMPLETED ·Phase: PHASE1
-
Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin
NCT01387048 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects
NCT00446043 ·Status: COMPLETED ·Phase: PHASE3